{
  "docId": "019dd923-622c-750b-8b98-be9011f05a27",
  "docSlug": "1cbf7684bf7d",
  "documentTitle": "Penumbra, Inc. (PEN)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-07-31 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 33,
  "pageCount": 61,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 18,
  "notes": "The chart uses a dual-axis combination (bar and line) to correlate revenue guidance raises with quarterly revenue beats.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bar_chart_vertical",
    "line_chart",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-be9011f05a27/33",
  "deckHref": "/decks/019dd923-622c-750b-8b98-be9011f05a27",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-be9011f05a27.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-be9011f05a27#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.72,
        "y": 0.58
      },
      "kind": "callout",
      "text": "Slimmest quarterly revenue beat since Q1 FY17",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5aa4cd4e-cf95-498d-b31b-6e92d7452e0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.72,
        "y": 0.69
      },
      "kind": "callout",
      "text": "No full-year revenue guidance raise. First failure to raise guidance since Q2 FY17",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "875bab75-f118-4a93-8597-b94692ab2c13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Could management be preparing the market for a near-term revenue miss?",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee3a-7528-92b6-8dd51cfc5542",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.65,
        "x": 0.05,
        "y": 0.32
      },
      "kind": "chart",
      "text": "Revenue Beats vs. Guidance Raises",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6752d349-8fb3-48e8-9a86-15335a84bf38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Quarterly Revenue Beat",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-ee3a-7528-92b6-90554093e7ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "paragraph",
      "text": "With Penumbra now facing significant on-label competition from large medical device manufacturers for the first time in its history, the competitive environment in which Penumbra has historically produced constant beats has radically changed through the last ~6 months. Investors and analysts may be expecting more of the same while transaction data reveals - in real time - that the world in which Penumbra could consistently grow neurovascular sales at double-digit rates simply no longer exists.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf70b8be-46b3-441e-9ec4-f5e450d0c716",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "As one would expect, management has historically been most likely to raise revenue guidance when achieving relatively larger quarterly revenue beats. While Penumbra has beaten analyst estimates every quarter since Q3 FY15, its last two beats were relatively slim - and, in Q1, management declined to raise full-year revenue guidance for the first time in almost two years. We are concerned by the fact that Penumbra is achieving slimmer revenue beats and declining to raise guidance just as IQVIA data indicates that its neurovascular aspiration catheter sales are slowing in the U.S. Could management be preparing the market for a near-term revenue miss?",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c71f6f1b-0191-4a90-8da3-0f3c49f7f967",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.38,
        "x": 0.31,
        "y": 0.05
      },
      "kind": "title",
      "text": "Management Gearing Up For A Miss?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23b4181b-42de-4ef7-ad4a-63274c08be01",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "expose_contradiction",
      "slug": null,
      "matchId": "67227f12-5eff-4122-8027-464cd3e0d044",
      "evidence": "Contrasts historical guidance raises with recent failure to raise guidance despite beats.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 61,
      "from": 31,
      "beatId": "12d3c67f-b91e-48ff-a8d3-c9685144b586",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The document presents Spruce Point's conclusion of 40-55% downside risk in PEN shares.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 36,
      "from": 33,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "8782ee2d-e1a4-4d74-988c-cda2e278820d",
      "evidence": "The document presents the potential consequences of not addressing competitive pressures.",
      "position": 1,
      "objective": "Highlighting the consequences of not addressing competitive pressures",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}